One-Shot cancer treatment? new nanoparticle therapy aims to control tough blood cancers

This study is testing a new type of CAR-T cell therapy for people with B-cell lymphoma or leukemia that has come back or hasn't responded to standard treatments. Instead of modifying a patient's T cells in a lab, the therapy uses tiny particles to deliver genetic instructions directly into the body to create cancer-fighting cells. Researchers want to see if this approach is safe, what dose works best, and if it can help control these difficult cancers.